Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced the appointment of Stuart Gall and Philip Rodgers as independent non-executive Directors of the Company, both with effect from 1 February 2024.
As announced in the Trading Update this morning, the Company has seen revenue growth of 7% in 2023 and an adjusted operating profit in the second half in a difficult economic environment and is positioned to deliver further growth in the future. The appointments will strengthen the Board to support these growth plans by adding additional commercial, investor relations and financial expertise. The additions to the Board take the number of non-executive directors to five; providing strengthened governance and succession for possible future rotation of Board members.
Stuart Gall is CEO of Intelligent Ultrasound, an AIM-listed medical imaging company providing one of the world’s leading ‘classroom to clinic’ ultrasound technologies.
